Trident Lifeline Limited (BOM:543616)

Market Cap	2.98B +8.0%
Revenue (ttm)	1.29B +48.4%
Net Income	190.41M +62.1%
EPS	16.32 +59.7%
Shares Out	11.93M
PE Ratio	15.31
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,400
Open	250.50
Previous Close	253.45
Day's Range	249.50 - 252.10
52-Week Range	229.95 - 328.00
Beta	-0.27
Analysts	n/a
Price Target	n/a
Earnings Date	May 7, 2026

About Trident Lifeline

Trident Lifeline Limited, together with its subsidiaries, manufactures and markets finished doses in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally. The company offers various medicinal products, including pharmaceuticals, nutraceuticals, herbals, and injectables in the form of tablets, capsules, dry powders for oral suspension, oral liquids, ointments, liquid ointments, effervescent tablets, sachets, pastes, gels, solutions, suspensions, ice gels, syrups, and creams, as well as toothpaste and mouthwash. Its products target...

• Industry: Pharmaceutical Preparations
• Founded: 2014
• Employees: 74
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543616

Financial Performance

In fiscal year 2026, Trident Lifeline's revenue was 1.29 billion, an increase of 48.36% compared to the previous year's 869.65 million. Earnings were 190.41 million, an increase of 62.08%.